Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null Mice

Background Keratoplasty is the most effective treatment for corneal blindness, but suboptimal medical conditions and lack of qualified medical personnel and donated cornea often prevent the performance of corneal transplantation in developing countries. Our study aims to develop alternative treatment regimens for congenital corneal diseases of genetic mutation. Methodology/Principal Findings Human mesenchymal stem cells isolated from neonatal umbilical cords were transplanted to treat thin and cloudy corneas of lumican null mice. Transplantation of umbilical mesenchymal stem cells significantly improved corneal transparency and increased stromal thickness of lumican null mice, but human umbilical hematopoietic stem cells failed to do the same. Further studies revealed that collagen lamellae were re-organized in corneal stroma of lumican null mice after mesenchymal stem cell transplantation. Transplanted umbilical mesenchymal stem cells survived in the mouse corneal stroma for more than 3 months with little or no graft rejection. In addition, these cells assumed a keratocyte phenotype, e.g., dendritic morphology, quiescence, expression of keratocyte unique keratan sulfated keratocan and lumican, and CD34. Moreover, umbilical mesenchymal stem cell transplantation improved host keratocyte functions, which was verified by enhanced expression of keratocan and aldehyde dehydrogenase class 3A1 in lumican null mice. Conclusions/Significance Umbilical mesenchymal stem cell transplantation is a promising treatment for congenital corneal diseases involving keratocyte dysfunction. Unlike donated corneas, umbilical mesenchymal stem cells are easily isolated, expanded, stored, and can be quickly recovered from liquid nitrogen when a patient is in urgent need.

[1]  S. Ikehara.  The Future of Stem Cell Transplantation in Autoimmune Disease , 2010, Clinical reviews in allergy & immunology.

[2]  Eric C. Carlson,et al.  Stem Cell Therapy Restores Transparency to Defective Murine Corneas , 2009, Stem cells.

[3]  J. Minguell,et al.  Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. , 2009, Heart, lung & circulation.

[4]  E. Geissler,et al.  Mesenchymal Stem Cells Can Affect Solid Organ Allograft Survival , 2009, Transplantation.

[5]  S. Hung,et al.  The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  M. Dezawa,et al.  Induction system of neural and muscle lineage cells from bone marrow stromal cells; a new strategy for tissue reconstruction in degenerative diseases. , 2009, Histology and histopathology.

[7]  A. Mobasheri,et al.  Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. , 2009, Histology and histopathology.

[8]  K. Brayman,et al.  The use of stem cells in kidney disease , 2009, Current opinion in organ transplantation.

[9]  Francesco Dazzi,et al.  Mesenchymal stem cells: the fibroblasts’ new clothes? , 2009, Haematologica.

[10]  L. Dai,et al.  The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. , 2009, Stem cell research.

[11]  M. Zurita,et al.  Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology. , 2009, Histology and histopathology.

[12]  J. Mao,et al.  Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues , 2008, PloS one.

[13]  M. Ko,et al.  Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord , 2008, PloS one.

[14]  N. Ashammakhi,et al.  Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. , 2008, Regenerative medicine.

[15]  T. Shman,et al.  Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro. , 2008, Experimental oncology.

[16]  J. Noolandi,et al.  Development of Hydrogel‐Based Keratoprostheses: A Materials Perspective , 2008, Biotechnology progress.

[17]  M. Soleimani,et al.  Multipotent mesenchymal stem cells from adult human eye conjunctiva stromal cells. , 2008, Differentiation; research in biological diversity.

[18]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[19]  Michael Kyba,et al.  Functional skeletal muscle regeneration from differentiating embryonic stem cells , 2008, Nature Medicine.

[20]  Eric C. Carlson,et al.  Keratocan and Lumican Regulate Neutrophil Infiltration and Corneal Clarity in Lipopolysaccharide-induced Keratitis by Direct Interaction with CXCL1* , 2007, Journal of Biological Chemistry.

[21]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[22]  S. Lipton,et al.  Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease , 2007, Nature Medicine.

[23]  Danish M. Khan,et al.  Advances in Boston Keratoprosthesis: Enhancing Retention and Prevention of Infection and Inflammation , 2007, International ophthalmology clinics.

[24]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[25]  Teruo Nishida,et al.  Noninvasive corneal stromal collagen imaging using two‐photon‐generated second‐harmonic signals , 2006, Journal of cataract and refractive surgery.

[26]  E. Pamer,et al.  Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation , 2006, Nature Medicine.

[27]  J. Hengstler,et al.  Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers , 2006, Gut.

[28]  L. Zangi,et al.  Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads , 2006, Bone Marrow Transplantation.

[29]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[30]  S. Geuna,et al.  Morphological characterization of GFP stably transfected adult mesenchymal bone marrow stem cells , 2006, Journal of anatomy.

[31]  G. Conrad,et al.  Focus on molecules: lumican. , 2006, Experimental eye research.

[32]  S Louise Moffatt,et al.  Centennial review of corneal transplantation , 2005, Clinical & experimental ophthalmology.

[33]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[34]  P. Garg,et al.  The value of corneal transplantation in reducing blindness , 2005, Eye.

[35]  Josef Bille,et al.  Second harmonic generation imaging of collagen fibrils in cornea and sclera. , 2005, Optics express.

[36]  Eric C. Carlson,et al.  Keratocan, a Cornea-specific Keratan Sulfate Proteoglycan, Is Regulated by Lumican* , 2005, Journal of Biological Chemistry.

[37]  Linbo Wu,et al.  In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells , 2005, Cell and Tissue Research.

[38]  K. Manova,et al.  Rescue of Cardiac Defects in Id Knockout Embryos by Injection of Embryonic Stem Cells , 2004, Science.

[39]  S. Tseng,et al.  CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. , 2004, Investigative ophthalmology & visual science.

[40]  F. Camargo,et al.  Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates , 2003, Nature Medicine.

[41]  H. Dua,et al.  Expression of CD34 and L-selectin on human corneal keratocytes. , 2003, Investigative ophthalmology & visual science.

[42]  Chia-Yang Liu,et al.  Keratocan-deficient Mice Display Alterations in Corneal Structure* , 2003, Journal of Biological Chemistry.

[43]  M. Mattson,et al.  Stem cells and aging: expanding the possibilities , 2001, Mechanisms of Ageing and Development.

[44]  W. Petroll,et al.  Measurement of corneal sublayer thickness and transparency in transgenic mice with altered corneal clarity using in vivo confocal microscopy , 2001, Vision Research.

[45]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[46]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[47]  W M Petroll,et al.  Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. , 2000, Investigative ophthalmology & visual science.

[48]  S. Saika,et al.  Role of Lumican in the Corneal Epithelium during Wound Healing* , 2000, The Journal of Biological Chemistry.

[49]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[51]  W M Petroll,et al.  Measurement of tissue thickness using confocal microscopy. , 1999, Methods in enzymology.

[52]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[53]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[54]  D. Sutherland,et al.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. , 1996, Journal of hematotherapy.